27 September 2022

ORPEA draws lessons from its Advanced Age General Review

On monday 26 September, ORPEA Group has organised the simultaneous presentation of its Advanced Age General Review in its nursing homes in France and announced a […]
12 September 2022

ORPEA releases preliminary unaudited financial indicators related to the first half of 2022

4 July 2022

ORPEA announces major changes in its board of Directors

Following the appointment of Laurent Guillot as ORPEA’s new Chief Executive Officer as of 1 July 2022, the ORPEA Group is announcing major changes in its […]
30 June 2022

ORPEA published the summary of the external assessment report on subjects relating to the care of nursing homes residents in France and to employment law

As per its commitment, the ORPEA Group has posted on its website the summary of the final conclusions of the audits carried out by Grant Thornton […]
8 June 2022

ORPEA publishes the summary of the external assessment report on the use of public funds and business relations with third parties

ORPEA announces that it has published on its website the summary of the final conclusions of Grant Thornton and Alvarez & Marsal’s audits regarding the allegations […]
19 May 2022

ORPEA HAS TAKEN NOTE OF INFORMATION PUBLISHED IN YESTERDAY’S PRESS

The Company has taken note of information published in yesterday’s press. The information refers to acts that were previously reported by the Company to the public […]
13 May 2022

Annual results 2021 and signature of an agreement in principle

ORPEA publishes its 2021 annual results and first quarter 2022 revenues. The Group announces the signature of an agreement in principle with its main banking partners.
2 May 2022

Laurent Guillot appointed as CEO of the Group

ORPEA’s Board of Directors has appointed Mr. Laurent Guillot as Chief Executive Officer of ORPEA, effective July 1st.
26 April 2022

Status update on the independent assessment by Grant Thornton and Alvarez & Marsal of the allegations made in the book “Les Fossoyeurs”

This document is an interim status update of the independent investigation performed by the firms Grant Thornton and Alvarez & Marsal who were together commissioned by […]